Skip to main content

Protalix Biotherapeutics (NY: PLX )

1.140 UNCHANGED
Official Closing Price Updated: 4:10 PM EDT, Apr 16, 2024 Add to My Watchlist

Other Filings

Form SC 13D/A
Source: SEC/Edgar
February 25, 2004
Form DEFA14A
Source: SEC/Edgar
February 24, 2004
Form SC 13D
Source: SEC/Edgar
February 22, 2004
Form DEFA14A
Source: SEC/Edgar
February 19, 2004
Form 8-K
Source: SEC/Edgar
February 19, 2004
Form 40-6C
Source: SEC/Edgar
February 18, 2004
Form SC 13G
Source: SEC/Edgar
February 16, 2004
Form SC 13G
Source: SEC/Edgar
January 26, 2004
Form 8-K
Source: SEC/Edgar
January 22, 2004
Form SC 13G/A
Source: SEC/Edgar
December 15, 2003
Form SC 13G
Source: SEC/Edgar
December 09, 2003
Form 8-K
Source: SEC/Edgar
December 04, 2003
Form SC 13D
Source: SEC/Edgar
November 30, 2003
Form 8-K
Source: SEC/Edgar
November 20, 2003
Form 10QSB
Source: SEC/Edgar
November 13, 2003
Form 8-K
Source: SEC/Edgar
November 11, 2003
Form 8-K
Source: SEC/Edgar
August 11, 2003
Form SC 13D/A
Source: SEC/Edgar
June 09, 2003
Form 10QSB
Source: SEC/Edgar
May 12, 2003
Form 8-K
Source: SEC/Edgar
May 01, 2003
Form SC 13D/A
Source: SEC/Edgar
April 22, 2003
Form ARS
Source: SEC/Edgar
April 20, 2003
Form DEF 14A
Source: SEC/Edgar
April 14, 2003
Form 8-K
Source: SEC/Edgar
February 26, 2003
Form 8-K
Source: SEC/Edgar
February 26, 2003
Form SC 13G
Source: SEC/Edgar
February 17, 2003
Form SC 13G
Source: SEC/Edgar
February 13, 2003
Form 8-K
Source: SEC/Edgar
January 01, 2003
Form 10QSB
Source: SEC/Edgar
November 14, 2002
Form 10QSB
Source: SEC/Edgar
November 13, 2002
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.